ANDA 78084, held by Baxter Healthcare. Metronidazole.
As of Nov 21, 2026, ANDA 78084 (Metronidazole In Plastic Container), held by Baxter Healthcare, was first approved by FDA on Mar 31, 2008, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole In Plastic Container500MG/100ML · injectable;injection | Metronidazole | Discontinued |
| Nov 8, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Nov 8, 2019 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 28, 2012 | Supplement 8Labeling | Approved | None posted |
| Apr 7, 2011 | Supplement 2Labeling | Approved | None posted |
| Jan 8, 2010 | Supplement 5Labeling | Approved | None posted |
| Nov 13, 2009 | Supplement 4Labeling | Approved | None posted |
| Jan 15, 2009 | Supplement 3Labeling | Approved | None posted |
| Mar 31, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters